Capstone Wealth Management (Alabama)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.26M Sell
1,087
-9
-0.8% -$10.6K 0.58% 24
2026
Q2
$1.31M Buy
1,096
+593
+118% +$606K 0.61% 23
2026
Q1
$463K Hold
503
– – 0.32% 33
2025
Q4
$541K Buy
503
+4
+0.8% +$3.82K 0.39% 30
2025
Q3
$381K Buy
499
+8
+2% +$5.95K 0.29% 38
2025
Q2
$383K Buy
491
+170
+53% +$132K 0.34% 33
2025
Q1
$265K Hold
321
– – 0.26% 42
2024
Q4
$248K Buy
+321
New +$266K 0.24% 41

Other funds holding LLY

Capstone Wealth Management (Alabama)'s LLY Position: Q3 2026 in Review

Capstone Wealth Management (Alabama) reduced its Eli Lilly (LLY) stake by 0.82% in Q3 2026, selling an estimated $10.6K and leaving 1,087 shares worth $1.26M. The position accounts for 0.58% of the portfolio, ranked #24.

Capstone Wealth Management (Alabama) first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.31M in Q2 2026. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Capstone Wealth Management (Alabama) held 1,087 shares of Eli Lilly worth $1.26M as of Q3 2026.
  • Capstone Wealth Management (Alabama) sold 9 Eli Lilly shares in Q3 2026, an estimated $10.6K.
  • Eli Lilly made up 0.58% of Capstone Wealth Management (Alabama)'s portfolio in Q3 2026, its #24 holding.
  • Capstone Wealth Management (Alabama) first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • Capstone Wealth Management (Alabama)'s Eli Lilly position peaked at $1.31M in Q2 2026.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Capstone Wealth Management (Alabama)'s 13F filing for Q3 2026, filed 2 Nov 2026.